Advertisement
Anteris Technologies Global Corp.

Anteris Technologies Global Corp. (AVR) Stock Overview

Explore Anteris Technologies Global Corp.’s financial performance, market position, analyst ratings, and future outlook.

AVRNASDAQ
HealthcareMedical - Devices
$9.69
$0.19(1.92%)
U.S. Market opens in 54h 50m
Advertisement

Anteris Technologies Global Corp. (AVR)

Meyka AI Score

Z

Key Financials

Market Cap356.5M
P/E Ratio-2.40
EPS (TTM)$-2.23
ROE-1.24%
Fundamental Analysis

AI Price Forecasts

1 Month$8.55
3 Months$8.67
1 Year Target$8.11

AVR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Anteris Technologies Global Corp. (AVR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 57.91, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $8.11.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.40 and a market capitalization of 356.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.92%
5-Day Change
-1.62%
1-Month Change
6.72%
3-Month Change
79.78%
6-Month Change
73.35%
Year-to-Date (YTD) Change
94.19%
1-Year Change
142.25%
3-Year Change
73.04%
5-Year Change
73.04%
All-Time (Max) Change
73.04%

Contact Information

61 13 0055 0310
Toowong Tower, Toowong, QLD, 4066

Company Facts

1,360 Employees
IPO DateDec 13, 2024
CountryAU
Actively Trading

Frequently Asked Questions